Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.84 USD | +7.42% | -3.16% | -23.75% |
May. 20 | Chinese Regulator Approves Zai Lab’s New Drug Application for Bacterial Pneumonia Drug | MT |
May. 20 | Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment | MT |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.92B | - | |||||
90.45B | ||||||
41.45B | ||||||
33.57B | ||||||
25.73B | ||||||
14.73B |
- Stock Market
- Equities
- ZLAB Stock
- Charts Zai Lab Limited
- Sector Chart